Colorectal Cancer Clinical Trial
Official title:
Evaluating a Preference-tailored Intervention to Increase CRC Screening in Primary Care Settings
RATIONALE: A computer program that provides information on colorectal cancer screening based
on a patient's test preferences may be more effective than a computer program that gives
standard information in helping patients get regular colorectal cancer screenings.
PURPOSE: This randomized clinical trial is studying computer-based tailored information to
see how well it works compared with standard information for colorectal cancer screening.
OBJECTIVES:
- To evaluate the effectiveness of a preference-tailored (PT) intervention vs standard
information (SI) delivered via computer for increasing patients' adherence to
colorectal cancer (CRC)-screening guidelines in a randomized controlled trial in two
racially/ethnically diverse geographic locations.
- To assess the impact of the intervention on patient perceptions of informed-decision
making, physician recommendation for CRC screening, decision conflict and satisfaction,
and intention to get screened 3 days after a primary care visit.
- To conduct a cost-effectiveness analysis of a preference-tailored strategy for
increasing CRC screening utilization.
OUTLINE: This is a multicenter study. Patients are randomized by the computer program to 1
of 3 intervention arms.
- Arm I (preference-tailored intervention): Patients receive overview information about
colorectal cancer (CRC), including graphics and descriptions of the colon and colon
polyps. Patients then complete a preference-assessment exercise test by using a
specially designed website. A brief description of the test is given at this time, and
patients are offered the option to learn more about their preference-matched test.
Patients are then given a list of other available CRC-screening tests with a brief
description and option to learn more about each test. The program informs them when all
information has been viewed. At the time the patients exit the program, or have viewed
all the information available, they are asked to choose which test is preferable to
receive from a list of existing test options.
- Arm II (standard information intervention): Patients receive overview information as in
arm I. The patients then use a website listing of the four existing CRC screening test
options along with graphical representations. They are allowed to interact with this
web page to view basic or more information about any or all of the tests. The program
informs them when all the information has been viewed. At this point, patients are
asked to choose which test they would prefer to receive from a list of existing test
options, as in arm I.
- Arm III (usual care): Patients receive usual care and do not receive any extra
educational materials. Patients may receive a telephone follow up at 12 months.
Upon completion of the intervention, patients in arms I and II receive a printout to take
with them to their upcoming appointment. For those in arm I, this printout will include
their top three attributes, their preference-matched test, and their final test choice. For
those in arm II, this printout will include a list of the four screening tests but will not
list their final test choice.
Patients in arm I and II undergo a 3-day follow-up telephone interview. Medical charts of
all patients in all 3 arms are reviewed at 12 months.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |